본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

만성정신분열병에서 Alprazolam 병용치료효과

이용수 0

영문명
Effects of Alprazolam - Combination Therapy in Chronic Schizophrenia
발행기관
대한신경정신의학회
저자명
서동혁 김창현 김용식
간행물 정보
『신경정신의학』제26권 제4호, 647~654쪽, 전체 8쪽
주제분류
의약학 > 정신과학
파일형태
PDF
발행일자
1987.11.30
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

This study had been conducted to elucidate the adjunctive antipsychotic effects of alprazolam in chronic schizophrenia. Thirty-eight hospitalized chronic schizophrenic patients who met DSM-III criteria and had been refractory to standard neuroleptic treatment were selected. The patients were subdivided into two groups; alprazolam combined group and placebo combined group. The duration of study is 7 weeks after two weeks’ washout period. The study consists of 3 stages-the 1st stage is two weeks’ period of dose increment, the 2nd stage is two weeks’ period of maintenance and the 3rd stage is three weeks’ tapering period. The clinical effect had been evaluated at four different time points-the beginning of the 1st week, the end of the 2nd week, the end of the 4th week and the end of the 7th week-by two psychiatrist who were blind for the nature of drugs administerd. The instruments for evaluation were Brief Psychiatric Rating Scale (BPRS) and Abrams-Taylor Rating Scale for Emotional Blunting (ATRS). The results were as follows: 1) Alprazolam combined group showed no significant difference in total scores and four subgroups, scores of BPRS, compared with placebo combined group during 7 weeks. 2) We found no significant changes in total BPRS scores and four subgroups,scores in the alprazolam combined group during the study. 3) There was significant difference between two groups in the evaluation of ARTS done at the time point of 4th week but the scores of alprazolam combined group were higher than those of placebo combined group. 4) Scores of ATRS and withdrawal-retardation subgroup in BPRS were shown to be increased during 1st and 2nd stages and decreased during 3rd stage, supposed to be due to sedative effect of alprazolam. From this study, we could not find any difference between alprazolam and placebo in the adjunctive antipsychotic effects in our study population. In order to more clarify the adjunctive antipsychotic effects of alprazolam, high-dose of alprazolam, longer duration and large sample size may be necessary.

목차

서 론
방 법
결 과
고 찰
결 론
REFERENCES

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

서동혁,김창현,김용식. (1987).만성정신분열병에서 Alprazolam 병용치료효과. 신경정신의학, 26 (4), 647-654

MLA

서동혁,김창현,김용식. "만성정신분열병에서 Alprazolam 병용치료효과." 신경정신의학, 26.4(1987): 647-654

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제